{
    "organizations": [],
    "uuid": "d88f0c43d191dd2db7550641bb90c2248c78ff27",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-immunomedics-announces-promising-d/brief-immunomedics-announces-promising-data-of-sacituzumab-govitecan-in-estrogen-receptor-positive-metastatic-breast-cancer-idUSFWN1SN0YU",
    "ord_in_thread": 0,
    "title": "BRIEF-Immunomedics Announces Promising Data Of Sacituzumab Govitecan In Estrogen Receptor-Positive Metastatic Breast Cancer",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Immunomedics Inc:\n* IMMUNOMEDICS ANNOUNCES PROMISING DATA OF SACITUZUMAB GOVITECAN IN ESTROGEN RECEPTOR-POSITIVE METASTATIC BREAST CANCER Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-17T05:16:00.000+03:00",
    "crawled": "2018-05-17T14:25:34.029+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "immunomedics",
        "inc",
        "immunomedics",
        "announces",
        "promising",
        "data",
        "sacituzumab",
        "govitecan",
        "estrogen",
        "metastatic",
        "breast",
        "cancer",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}